$25.85−0.56 (−2.12%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Elanco Animal Health (ELAN) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~−0.3%/yr (FY21→FY25), net margin −4.9%. Worth your attention in FY25: Capex step-up ($276.0M). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲6.2%
4,715.0
FY21→FY25CAGR −0.3%/yr
Net income ($M)—
−232.0
one-off year: see footnoteCAGR —
Free cash flow ($M)▼27.9%
284.0
capex stepped upCAGR −3.2%/yr
Diluted EPS—
−0.47
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+1.9%
487.2mn → 496.4mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.
Capex step-up
$276.0M
▲88% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-5¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 55.2% → 55.0%. Net margin -4.9% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 5,148.0 | 4,715.0 | 4,439.0 | 4,417.0 | 4,411.0 | 4,764.0 | ▲6.2% | −0.3% |
Cost of revenue | 2,256.0 | 2,122.0 | 2,003.0 | 1,931.0 | 1,913.0 | 2,132.0 | ▲5.9% | −0.1% |
Gross profit | 2,892.0 | 2,593.0 | 2,436.0 | 2,486.0 | 2,498.0 | 2,632.0 | ▲6.4% | −0.4% |
Research & development | 381.0 | 368.0 | 344.0 | 327.0 | 321.0 | 369.0 | ▲7.0% | −0.1% |
Selling, general & admin | 1,561.0 | 1,430.0 | 1,314.0 | 1,285.0 | 1,265.0 | 1,403.0 | ▲8.8% | +0.5% |
Total operating expenses | 2,752.0 | 2,597.0 | 2,353.0 | 3,404.0 | 2,329.0 | 2,967.0 | ▲10.4% | −3.3% |
Operating incomefeeds ROC rank | 140.0 | −4.0 | 83.0 | −918.0 | 169.0 | −335.0 | — | — |
Other income, net | −232.0 | −220.0 | 405.0 | −277.0 | −241.0 | −236.0 | — | — |
Pretax income | −92.0 | −224.0 | 488.0 | −1,195.0 | −72.0 | −571.0 | — | — |
Income tax | 55.0 | 8.0 | 150.0 | 36.0 | 6.0 | −88.0 | ▼94.7% | +10.1% (22→25) |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −147.0 | −232.0 | 338.0 | −1,231.0 | −78.0 | −483.0 | — | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.29 | −0.47 | 0.68 | −2.50 | −0.16 | −0.99 | — | — |
Diluted shares (mn) | 506.50 | 496.40 | 497.30 | 492.30 | 488.30 | 487.20 | ▼0.2% | +0.5% |
| Margins | ||||||||
Gross margin37th pct in Healthcare | 56.2% | 55.0% | 54.9% | 56.3% | 56.6% | 55.2% | ▲0.1pp | −0.3pp |
Operating margin | 2.7% | −0.1% | 1.9% | −20.8% | 3.8% | −7.0% | ▼2.0pp | +6.9pp |
Net margin34th pct in Healthcare | −2.9% | −4.9% | 7.6% | −27.9% | −1.8% | −10.1% | ▼12.5pp | +5.2pp |
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 15% vs a −3% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was 31% vs a −3% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Elanco Animal Health's revenue last fiscal year?
Elanco Animal Health reported revenue of $4,715.0M in fiscal 2025, up 6.2% from fiscal 2024.
What was Elanco Animal Health's net income?
Elanco Animal Health reported net income of −$232.0M in fiscal 2025, a net margin of −4.9%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

